— ONE INTEGRATED ADVISORY —
Aleso is a boutique advisory firm at the intersection of corporate finance, healthcare, and technology — founded in São Paulo, Brazil, in 2021 and expanded to the US through Aleso & Company LLC in Tampa, bringing the same methodology, sector depth, and cross-border expertise to both markets.
Aleso was built around a combination rarely found within a single advisory firm: deep financial engineering expertise — rooted in Big Four transaction advisory and operations transformation — alongside hands-on experience in healthcare technology, pharmaceutical market access, hospital strategy, and patient-centered care innovation. It is this integrated model that Aleso & Company brings to the US mid-market.
What distinguishes Aleso is the depth of its integrated perspective. The convergence of finance, healthcare, and technology is the foundation of the firm's ability to navigate complex, high-stakes client environments with a level of clarity and insight that only emerges when all three domains work together.
Aleso was built around two core areas of expertise — financial advisory and healthcare — where technology and innovation run through every engagement.
Clients who demand rigorous financial expertise, deep sector knowledge, or both — across corporate finance, healthcare and technology.
A select group of associated senior advisors bringing specialized expertise across finance, healthcare, and pharma.
Selected media coverage, industry publications, and institutional recognition of Aleso's work across healthcare innovation, oncology technology, and financial advisory.
Analysis of the one-person billion-dollar company thesis and its implications for the future of advisory and healthtech.
Brazil's leading financial newspaper covers the MEDVi case and the emerging model of lean, high-impact advisory firms.
Estadão covers the rise of healthtech companies in Brazil, featuring Aleso's work in oncology patient navigation.
Published analysis on cancer care trends and the strategic role of digital health platforms in oncology access.
Feature on the launch of Ana Saúde — Brazil's first 100% digital oncology clinic, founded under the Aleso brand.
Leading Brazilian startup media covers the launch and vision behind Ana Saúde's anywhere-care oncology model.
Coverage of the largest healthcare M&A transaction in Brazil's North-Northeast region in 2019, in which Aleso's founding advisor played a central advisory role.
Honco selected as one of only four case reports ever awarded in the entire history of Barretos Cancer Hospital's innovation program — Latin America's largest cancer center.
Honco selected and recognized within Brazil's national innovation initiative supported by the Brazilian Development Bank (BNDES) — validating the platform's technical robustness and public-interest impact.
National recognition by one of Latin America's leading diagnostic medicine institutions, awarded for the design and implementation of a technology-enabled oncology patient journey.
Honco's oncology patient navigation model recognized as a Top 5 initiative by Brazil's national development bank among all submitted healthcare innovation projects.
Honco's patient navigation methodology and clinical outcomes presented at Brazil's national hospital congress, demonstrating measurable impact across oncology care coordination.
Honco selected for the prestigious acceleration program at Hospital de Amor Barretos in partnership with SEBRAE, validating the platform's clinical model and scalability potential.
